Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 796 AL 810

Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I.

Acta Neuropathol. 2021 Apr;141(4):511-526. doi: 10.1007/s00401-021-02266-7. Epub 2021 Jan 30.

Thirty years of research on autonomic dysfunction, non-motor features, and endophenotypes in Parkinson disease

Chaudhuri KR.

Clin Auton Res. 2021 Feb;31(1):37-39. doi: 10.1007/s10286-021-00771-z. Epub 2021 Jan 30.

Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases

Gage MC, Thippeswamy T.

CNS Drugs. 2021 Jan;35(1):1-20. doi: 10.1007/s40263-020-00787-5. Epub 2021 Jan 30.

The potential of biomaterials for central nervous system cellular repair

Jarrin S, Cabré S, Dowd E.

Neurochem Int. 2021 Mar;144:104971. doi: 10.1016/j.neuint.2021.104971. Epub 2021 Jan 28.

Co-occurring SYNJ1 and SHANK3 variants in a girl with intellectual disability, early-onset parkinsonism and catatonic episodes

Galosi S, Martinelli S, Pannone L, Terrinoni A, Venditti M, Pizzi S, Ciolfi A, Chillemi G, Gigliotti F, Cesario S, Tartaglia M, Leuzzi V.

Parkinsonism Relat Disord. 2021 Mar;84:5-7. doi: 10.1016/j.parkreldis.2020.12.022. Epub 2021 Jan 12.

Contribution of astrocytes to neuropathology of neurodegenerative diseases

Acioglu C, Li L, Elkabes S.

Brain Res. 2021 May 1;1758:147291. doi: 10.1016/j.brainres.2021.147291. Epub 2021 Jan 28.

14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases

Pair FS, Yacoubian TA.

Trends Pharmacol Sci. 2021 Apr;42(4):226-238. doi: 10.1016/j.tips.2021.01.001. Epub 2021 Jan 28.

Appendectomy Does Not Increase the Risk of Future Emergence of Parkinson's Disease: A Meta-analysis

Ishizuka M, Shibuya N, Takagi K, Hachiya H, Tago K, Suda K, Aoki T, Kubota K.

Am Surg. 2021 Nov;87(11):1802-1808. doi: 10.1177/0003134821989034. Epub 2021 Jan 30.

Body-Worn Sensors for Remote Monitoring of Parkinson's Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead

Del Din S, Kirk C, Yarnall AJ, Rochester L, Hausdorff JM.

J Parkinsons Dis. 2021;11(s1):S35-S47. doi: 10.3233/JPD-202471.

COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?

Bloem BR, Trenkwalder C, Sanchez-Ferro A, Kalia LV, Alcalay R, Chiang HL, Kang UJ, Goetz C, Brundin P, Papa SM.

J Parkinsons Dis. 2021;11(1):3-8. doi: 10.3233/JPD-212573.

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease

Simmering JE, Welsh MJ, Liu L, Narayanan NS, Pottegård A.

JAMA Neurol. 2021 Apr 1;78(4):407-413. doi: 10.1001/jamaneurol.2020.5157.

A Comprehensive Meta-analysis on Short-term and Working Memory Dysfunction in Parkinson's Disease

Ramos AA, Machado L.

Neuropsychol Rev. 2021 Jun;31(2):288-311. doi: 10.1007/s11065-021-09480-w. Epub 2021 Feb 1.

Harnessing the immune system for the treatment of Parkinson's disease

Vedam-Mai V.

Brain Res. 2021 May 1;1758:147308. doi: 10.1016/j.brainres.2021.147308. Epub 2021 Jan 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias